C4 Therapeutics Stock Target Price and Analyst Consensus
| CCCC Stock | USD 4.55 0.36 8.59% |
The current analyst and expert consensus on C4 Therapeutics is Strong Buy, with 4 strong buy opinions. The current projected C4 Therapeutics target price consensus is 18.20 with 7 analyst opinions. Check out Macroaxis Advice on C4 Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade CCCC Stock refer to our How to Trade CCCC Stock guide.The most common way C4 Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview C4 Therapeutics executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on C4 Therapeutics. We strongly encourage you to use your own analysis of C4 Therapeutics to validate this buy or sell advice. C4 Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected C4 Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 5.0641.
Lowest Forecast 16.56 | Highest Forecast 20.2 | Target Price 18.2 |
CCCC |
It's important to approach C4 Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize C4 Therapeutics price targets
C4 Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using C4 Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at C4 Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if C4 Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional C4 Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of C4 Therapeutics is a key component of C4 Therapeutics valuation and have some predictive power on the future returns of a C4 Therapeutics.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of C4 Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested few shares | |
 | Momentum Invested few shares | |
 | Adviser Favorites Invested few shares | |
 | Dividend Beast Invested over 50 shares | |
 | Baby Boomer Prospects Invested over 60 shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Business Services Invested few shares | |
 | Automobiles and Trucks Invested over 200 shares | |
 | Power Assets Invested over 200 shares | |
 | Hedge Favorites Invested few shares | |
 | Corona Opportunity Invested few shares | |
Check out Macroaxis Advice on C4 Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade CCCC Stock refer to our How to Trade CCCC Stock guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Please note, the presentation of C4 Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, C4 Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of C4 Therapeutics' management manipulating its earnings.